Grey Wolf

News

Immuno-oncology biotech Grey Wolf Therapeutics has raised £10 million in series A financing to develop therapies that increase tumour visibility.

News

ITM's first attempt to score FDA approval for one of its radiopharma therapies has been knocked back by the agency.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.